Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
34 hedge funds and large institutions have $5.76M invested in Zosano Pharma Corporation in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 15 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
21% less funds holding
Funds holding: 43 → 34 (-9)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
75% less capital invested
Capital invested by funds: $23.1M → $5.76M (-$17.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$200K |
| 2 |
TI
Telemetry Investments
New York
|
+$160K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$127K |
| 4 |
VF
Virtu Financial
New York
|
+$111K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$68.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
-$1.9M |
| 2 |
CCM
CAAS Capital Management
New York
|
-$734K |
| 3 |
Morgan Stanley
New York
|
-$705K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$479K |
| 5 |
Renaissance Technologies
New York
|
-$447K |
ZSAN Hedge Fund Activity: Q4 2020 in Review
34 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q4 2020, worth a combined $5.76M — down 75% from $23.1M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ZSAN and 6 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 8 added.
The largest buyer was Vanguard Group, adding an estimated $200K. The largest seller was Jess S. Morgan & Co, exiting entirely with an estimated $1.9M sold.
- 34 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q4 2020, down from 43 in Q3 2020.
- Funds reported $5.76M of Zosano Pharma Corporation stock for Q4 2020, down 75% quarter-over-quarter.
- 6 funds opened new Zosano Pharma Corporation positions in Q4 2020 and 15 closed out, a net change of -9 holders.
- The largest Zosano Pharma Corporation buyer in Q4 2020 was Vanguard Group, an estimated $200K added.
- The largest Zosano Pharma Corporation seller in Q4 2020 was Jess S. Morgan & Co, an estimated $1.9M sold.
Based on aggregated 13F filings for Q4 2020.